The effect of preoperative pulmonary protection on surfactant protein A content in lung tissue
10.11958/20161397
- VernacularTitle:术前肺保护对肺组织肺表面活性蛋白A含量的影响
- Author:
Mingyou CHI
;
Xiaodong WANG
;
Xin LI
;
Daqiang SUN
- Keywords:
pulmonary disease;
chronic obstructive;
pulmonary surfactant- associated protein A;
postoperative complications;
respiratory function tests;
preoperative pulmonary protection therapy;
exhaled breath condensate
- From:
Tianjin Medical Journal
2017;45(3):310-313
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of preoperative pulmonary protection therapy on surfactant protein A(SP–A) content in lung tissue and postoperative complications. Methods Sixty patients with non-small cell lung cancer (NSCLC) complicated with chronic obstructive pulmonary disease(COPD) who underwent surgical treatment in Tianjin Chest Hospital from January 2015 to June 2016 were enrolled in this study. Thirty patients were included in the control group and 30 patients in the pulmonary protection group. The control group was given routine preoperative preparation, while the pulmonary protection group was given 1 week pulmonary protection therapy on the basis of routine preoperative preparation. The exhaled breath condensate (EBC) was collected and pulmonary function was re-checked after admission and before surgery. The content of SP-A in EBC was detected by ELISA. The lung tissue samples were collected during surgery, and the SP-A level was measured by Western blotting. Results The SP-A level of the pulmonary protection group was significantly higher than that of the control group (1.05±0.21 vs. 0.93±0.16, P<0.05). The SP-A content in the preoperative EBC of the pulmonary protection group was significantly higher than that after admission[(5.51 ± 1.48) ng/L vs. (4.99 ± 1.32) ng/L, P<0.01]. After pulmonary protection treatment, the preoperative pulmonary function index was significantly higher than that after admission (P<0.01). There was no significant difference in the incidence of postoperative pulmonary complications between two groups (23.3%vs. 43.3%, P>0.05). The average postoperative hospital stay was statistically significant shorter in the pulmonary protection group than that in the control group[(9.2 ± 3.1) d vs. (11.6 ± 4.8) d, P<0.05]. Conclusion Preoperative pulmonary protection therapy can not only improve pulmonary function and shorten postoperative hospital stay, but also improve SP-A content in lung tissue.
